OTCMKTS:SBMFF

Sino Biopharmaceutical Stock Forecast, Price & News

$0.96

-0.01 (-0.52 %)

(As of 01/27/2021 02:56 PM ET)

Add

Compare

Today's Range

$0.96

Now: $0.96▼

$1.00

50-Day Range

$0.85

MA: $0.96▼

$1.03

52-Week Range

$0.79

Now: $0.96▼

$1.92

Volume10,800 shs

Average Volume5,055 shs

Market Capitalization$18.03 billion

P/E RatioN/A

Dividend YieldN/A

Beta0.57

Sino Biopharmaceutical Limited, together with its subsidiaries, operates as a research and development pharmaceutical conglomerate in the People's Republic of China. The company operates in three segments: Chinese Medicines, Investment, and Others. Its principal products include hepatitis medicines, such as Tianqingganmei injections and Tianqingganping enteric capsules; oncology medicines comprising Saiweijian injections, Yinishu tablets, Shoufu tablets, Anxian capsules, and Qianping injections; cardio-cerebral medicines, including Yilunping tablets, Tuotuo tablets, and Kaina tablets; and orthopedic medicines, such as Gaisanchun capsules and Yigu injections. The company's principal products also comprise digestive system medicines that consist of Aisuping injections, Getai tablets, and Deyou granules; anti-infectious medicines that include Tiance injections, Tianjie injections, and Tianli injections; respiratory system medicines, such as Tianqingsule inhalation powder; and others comprising Debaian cataplasms. In addition, it engages in property holding activities; the retail and distribution of pharmaceutical products; optometry for optical glasses and sale of ophthalmic products; the provision of medical management consultancy services; and outpatient and surgical procedure. Further, the company manufactures, sells, and distributes health food; and develops medical technology. Sino Biopharmaceutical Limited was incorporated in 2000 and is headquartered in Wan Chai, Hong Kong.

MarketRank^™

Overall MarketRank^™

0.82 out of 5 stars

Medical Sector

1105th out of 1,926 stocks

Private Households Industry

197th out of 378 stocks

0.0 Analyst's Opinion

Consensus Rating
There is not enough analysis data for Sino Biopharmaceutical.

2.2 Community Rank

Outperform Votes
Sino Biopharmaceutical has received 103 “outperform” votes. (Add your “outperform” vote.)
Underperform Votes
Sino Biopharmaceutical has received 136 “underperform” votes. (Add your “underperform” vote.)
Community Sentiment
Sino Biopharmaceutical has received 56.90% “underperform” votes from our community.

MarketBeat's community ratings are surveys of what our community members think about Sino Biopharmaceutical and other stocks. Vote “Outperform” if you believe SBMFF will outperform the S&P 500 over the long term. Vote “Underperform” if you believe SBMFF will underperform the S&P 500 over the long term. You may vote once every thirty days.

0.0 Dividend Strength

Dividend Yield
Sino Biopharmaceutical does not currently pay a dividend.
Dividend Growth
Sino Biopharmaceutical does not have a long track record of dividend growth.

0.0 Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Sino Biopharmaceutical insiders have not sold or bought any company stock.

1.9 Earnings and Valuation

Earnings Growth
Earnings for Sino Biopharmaceutical are expected to grow by 50.00% in the coming year, from $0.02 to $0.03 per share.
Price to Book Value per Share Ratio
Sino Biopharmaceutical has a P/B Ratio of 3.08. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

Industry, Sector and Symbol

Stock Exchange OTCMKTS

Industry Private households

Sub-IndustryN/A

SectorMedical

Current SymbolOTCMKTS:SBMFF

Previous SymbolNASDAQ:SBMFF

CUSIPN/A

CIKN/A

Webwww.sinobiopharm.com

Phone852-2802-9886

Employees23,475

Year FoundedN/A

Debt

Debt-to-Equity Ratio0.35

Current Ratio3.27

Quick Ratio3.09

Price-To-Earnings

Trailing P/E RatioN/A

Forward P/E RatioN/A

P/E GrowthN/A

Sales & Book Value

Annual Sales$3.51 billion

Price / Sales5.14

Cash Flow$0.05 per share

Price / Cash Flow19.49

Book Value$0.31 per share

Price / Book3.08

Profitability

EPS (Most Recent Fiscal Year)N/A

Net IncomeN/A

Net MarginsN/A

Return on EquityN/A

Return on AssetsN/A

Miscellaneous

Outstanding Shares18,882,450,000

Market Cap$18.03 billion

Next Earnings DateN/A

OptionableNot Optionable

$0.96

-0.01 (-0.52 %)

(As of 01/27/2021 02:56 PM ET)

30 days | 90 days | 365 days | Advanced Chart

Receive SBMFF News and Ratings via Email

Sign-up to receive the latest news and ratings for SBMFF and its competitors with MarketBeat's FREE daily newsletter.

Sino Biopharmaceutical (OTCMKTS:SBMFF) Frequently Asked Questions

How has Sino Biopharmaceutical's stock been impacted by Coronavirus (COVID-19)?

Sino Biopharmaceutical's stock was trading at $1.44 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, SBMFF shares have decreased by 33.7% and is now trading at $0.9550.
View which stocks have been most impacted by COVID-19.

Is Sino Biopharmaceutical a buy right now?

4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Sino Biopharmaceutical in the last year. There are currently 2 hold ratings and 2 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" Sino Biopharmaceutical stock.
View analyst ratings for Sino Biopharmaceutical or view MarketBeat's top 5 stock picks.

What stocks does MarketBeat like better than Sino Biopharmaceutical?

Wall Street analysts have given Sino Biopharmaceutical a "Buy" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Sino Biopharmaceutical wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

Are investors shorting Sino Biopharmaceutical?

Sino Biopharmaceutical saw a decrease in short interest during the month of December. As of December 31st, there was short interest totaling 16,368,400 shares, a decrease of 18.0% from the December 15th total of 19,966,000 shares. Based on an average trading volume of 60,400 shares, the short-interest ratio is presently 271.0 days.
View Sino Biopharmaceutical's Short Interest.

Who are some of Sino Biopharmaceutical's key competitors?

Some companies that are related to Sino Biopharmaceutical include Atlas Copco (ATLKY), Daikin Industries,Ltd. (DKILY), Deutsche Post (DPSGY), Vinci (VCISY), Bayerische Motoren Werke Aktiengesellschaft (BAMXF), Pjsc Lukoil (LUKOY), Oriental Land (OLCLY), HOYA (HOCPY), Vestas Wind Systems A/S (VWDRY), DENSO (DNZOY), ITOCHU (ITOCY), SMC (SMCAY), A.P. Møller - Mærsk A/S (AMKBY), Jardine Matheson (JMHLY) and Henkel AG & Co. KGaA (HENKY).
View all of SBMFF's competitors.

Who are Sino Biopharmaceutical's key executives?

Sino Biopharmaceutical's management team includes the following people:

Mr. Ping Tse, Founder & Sr. Vice Chairman (Age 68)
Ms. Cheung Ling Cheng, Exec. Vice Chairwoman of the Board (Age 56)
Ms. Mingqin Li, VP & Exec. Director (Age 61)
Mr. Zhoushan Tian, Exec. Director (Age 56)
Mr. Hsin Tse, VP & Exec. Director (Age 50)
Mr. Eric S. Y. Tse, Exec. Director (Age 24)
Ms. Y. Y. Tse, Exec. Chairman (Age 28)
Mr. Yi Li, CEO & Exec. Director (Age 58)
Ms. Jiayin Jennie Ma, Group Chief Financial Officer (Age 44)
Ms. Fai Chia, VP & Assistant to the Founding Chairman (Age 62)

What is Sino Biopharmaceutical's stock symbol?

Sino Biopharmaceutical trades on the OTCMKTS under the ticker symbol "SBMFF."

How do I buy shares of Sino Biopharmaceutical?

Shares of SBMFF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Sino Biopharmaceutical's stock price today?

One share of SBMFF stock can currently be purchased for approximately $0.96.

How big of a company is Sino Biopharmaceutical?

Sino Biopharmaceutical has a market capitalization of $18.03 billion and generates $3.51 billion in revenue each year. Sino Biopharmaceutical employs 23,475 workers across the globe.

What is Sino Biopharmaceutical's official website?

The official website for Sino Biopharmaceutical is www.sinobiopharm.com.

How can I contact Sino Biopharmaceutical?

Sino Biopharmaceutical's mailing address is Rm 4109 Office Tower Convention Plaza 1 Harbour Road Wanchai, Hong Kong K3, . The company can be reached via phone at 852-2802-9886 or via email at [email protected]

This page was last updated on 1/27/2021 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Sino Biopharmaceutical Stock Forecast, Price & News

Adding